Alberta Innovates has proudly announced the Exploring Cannabis-Based Medicines and Tools (mCannabis) Program on December 9, 2019.
The said program aims to provide new opportunity for stakeholders in Alberta’s Cannabis ecosystem collaboration.
In connection with this, the coordination between stakeholders is projected to result to advance Cannabis research and innovations that aim to enhance patient care, improve patient outcomes, support the training of healthcare professionals, and responsibly grow Canada’s Cannabis industry.
These opportunities will align to Alberta Innovates’ three research and innovation priorities, the Alberta Research and Innovation Framework (ARIF), and will create economic and health value for Alberta citizens.
Also, Alberta Innovates acknowledges the collaborative support from the Campus Alberta Neurosciences during launching of the program.
Objectives of mCannabis Program:
- Understand Cannabis phytochemicals for putative pain or analgesic properties (Stream 1).
- To improve patient outcomes and to responsibly grow Canada’s Cannabis Industry by understanding how Alberta Innovates can support the use of post-market surveillance data (Stream 2).
- Provide a platform of engagement among medical Cannabis stakeholders to coordinate and collaborate to generate evidence and knowledge for more informed Cannabis use.
- Provide advisory support for entities seeking engagement and input with healthcare delivery professionals and patients.
- To promote Alberta-based research and innovation into local and global markets to support Canada’s Cannabis industry.
- To realize economic and health benefits for Albertans.
Benefits of mCannabis Program:
Projects that are up to $300,000 for a maximum term of 24 months will be supported by the said program.
Who can apply:
- For potential Applicants seeking funding support for Stream 1 (i.e., phytochemicals and pain), Applicants must demonstrate a significant legal and physical presence in Alberta.
- This opportunity is intended for any interested parties working with Cannabis. For potential Applicants seeking to contribute Big Ideas for Stream 2 (i.e., request for ideas – how can Alberta Innovates support the use of post-market data), anyone can apply. Intake is open to all Cannabis-related stakeholders.
Deadline of Application: Applications will be accepted until 4:00 pm MST, January 29, 2020.
If you are interested in Exploring Cannabis-Based Medicines and Tools (mCannabis) Program or tax incentives and other sources of funding, schedule a call with EVAMAX for a free grant consultation.